Piperidine → Phe-Gly

HRID 39263

반응식

HRID 39263 반응식
C1C2C(COC([NH:18][C@H:19]([C:27]([NH:29][CH2:30][C:31]([OH:33])=[O:32])=[O:28])[CH2:20][C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=3)=O)C3C(=CC=CC=3)C=2C=CC=1.N1CCCCC1>CN(C=O)C>[NH2:18][C@H:19]([C:27]([NH:29][CH2:30][C:31]([OH:33])=[O:32])=[O:28])[CH2:20][C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1

참가 물질

4

반응물 2

HCID 8082PiperidineHCID 11328236Fmoc-Phe-Gly-OH

생성물 1

HCID 6992304Phe-Gly

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

Fmoc-protected dipeptide 72 (500 mg, 1.00 mmol) was treated with a 5% v/v solution of piperidine in DMF (5 mL). After stirring for 1 h, the reaction mixture was concentrated to dryness. The crude material was used for the next step without purification.

후처리

  1. concentrationthe reaction mixture was concentrated to dryness
  2. customThe crude material was used for the next step without purification

출처 및 근거

ORD 기록
ord-f2ae1b8090a940d2913985de4b8df854
출처 데이터셋
uspto-grants-2013_09
특허 번호
US08524691B2

연결된 노트

불러오는 중…